<<

Revisions to USP 31–NF 26, Second Supplement

(published May 2008) Published April 2008

General Chapters Monographs:A–C D–N O–S T–Z

Monograph Title Section Head Scientific Liaison DANTROLENE SODIUM Dissolution <711> CAPSULES PF 33(4) Pg. 645 DEHYDROACETIC ACID PF 33(4) Title Pg. 703 DEHYDROACETIC ACID PF 33(4) Chemical Info Pg. 703 DEHYDROACETIC ACID PF 33(4) Definition Pg. 703 DEHYDROACETIC ACID PF 33(4) Packaging and storage Pg. 703 DEHYDROACETIC ACID PF 33(4) USP Reference standards <11> Pg. 703 DEHYDROACETIC ACID PF 33(4) Identification Pg. 703 DEHYDROACETIC ACID PF 33(4) Heavy Metals, Method II <231> Pg. 703 DEHYDROACETIC ACID PF 33(4) Loss on drying <731> Pg. 703 DEHYDROACETIC ACID PF 33(4) Melting range, Class I <741> Pg. 703 DEHYDROACETIC ACID PF 33(4) Residue on ignition <281> Pg. 703 DEHYDROACETIC ACID PF 33(4) Assay Pg. 703 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Title 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Definition 784

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Packaging and storage 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Labeling 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. USP Reference stadards 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Identification 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Uniformity of dosage units 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Loss on drying 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Related compounds 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Assay 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Title 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Definition 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Labeling 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Loss on drying <731> 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Acid-neutralizing capacity <301> 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Related compounds 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Assay

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] 903 DILTIAZEM HYDROCHLORIDE Definition PF 33(5) Pg. 907 DIMENHYDRINATE INJECTION USP Reference standards <11> PF 33(5) Pg. 907 DIMENHYDRINATE INJECTION Identification PF 33(5) Pg. 907 DIMENHYDRINATE PF 33(5) Pg. Identification 907 DINOPROST TROMETHAMINE Title INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Definition INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Packaging and storage INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Labeling INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE USP Reference standards <11> INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Identification INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Bacterial endotoxins <85> INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Sterility <71> INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE pH <791> INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Other requirements INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE Assay INJECTION PF 33(5) Pg. 908 ENOXAPARIN SODIUM Title INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Definition INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Packaging and storage INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Labeling INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM USP Reference standards file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Identification A, B, C INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Clarity INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Color INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM pH INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Benzyl content INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Free sulfate content INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Anti-factor IIa activity INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Anti-factor Xa to anti-factor IIa ratio INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Other requirements - Sterility Tests INJECTION PF 31(3) Pg. 761 <71> ENOXAPARIN SODIUM Other requirements INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Assay (anti-factor Xa activity) INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Bacterial endotoxins INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM Definition INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM Appearance of solution (Clarity and INJECTION PF 33(1) Pg. 58 degree of color of liquids) ENOXAPARIN SODIUM content (if present) INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM Bacterial endotoxins <85> INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM Free sulfate content INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM Assay (anti-factor Xa activity) INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM PF 29(6) Title Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Chemical structure file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] Pg. 1876 ENOXAPARIN SODIUM PF 29(6) CAS number Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Definition Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Packaging and storage Pg. 1876 ENOXAPARIN SODIUM PF 29(6) USP Reference standards Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Identification A, B, C, D, E Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Appearance of solution Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Specific absorbance Pg. 1876 ENOXAPARIN SODIUM PF 29(6) pH Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Loss on drying Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Nitrogen content Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Heavy metals Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Sodium content Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Molar ratio of sulfate to carboxylate Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Benzyl alcohol content Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Anti-factor IIa activity Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Assay (anti-factor Xa activity) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Bacterial endotoxins Pg. 1876 ENOXAPARIN SODIUM PF 33(1) Definition Pg. 52 ENOXAPARIN SODIUM PF 33(1) USP Reference standards <11> Pg. 52 ENOXAPARIN SODIUM PF 33(1) Identification file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] Pg. 52 ENOXAPARIN SODIUM PF 33(1) Appearance of solution (Clarity and Pg. 52 degree of color of liquids) ENOXAPARIN SODIUM PF 33(1) pH <791> Pg. 52 ENOXAPARIN SODIUM PF 33(1) Molar ratio of sulfate to carboxylate Pg. 52 (see Chromatography <621>) ENOXAPARIN SODIUM PF 33(1) Benzyl alcohol content Pg. 52 ENOXAPARIN SODIUM PF 33(1) Anti-factor IIa activity Pg. 52 ENOXAPARIN SODIUM PF 33(1) Assay (anti-factor Xa activity) Pg. 52 AND NORETHINDRONE ACETATE Dissolution TABLETS PF 31(5) Pg. 1364 ESTRADIOL AND NORETHINDRONE ACETATE Dissolution TABLETS PF 33(2) Pg. 220 ETHINYL ESTRADIOL TABLETS Disintegration PF 31(4) Pg. 1067 ETHIONAMIDE PF 33(4) Pg. 648 Assay FAMOTIDINE TABLETS PF 33(4) Dissolution <711> Pg. 649 FORMALDEHYDE SOLUTION PF Definition 33(4) Pg. 650 FORMALDEHYDE SOLUTION PF Labeling 33(4) Pg. 650 FORMALDEHYDE SOLUTION PF Content of 33(4) Pg. 650 FORMALDEHYDE SOLUTION PF Assay 33(4) Pg. 650 FULVESTRANT PF 33(5) Pg. 909 Title FULVESTRANT PF 33(5) Pg. 909 Chemical Info FULVESTRANT PF 33(5) Pg. 909 Definition FULVESTRANT PF 33(5) Pg. 909 Packaging and storage FULVESTRANT PF 33(5) Pg. 909 USP Reference standards <11> FULVESTRANT PF 33(5) Pg. 909 Identification FULVESTRANT PF 33(5) Pg. 909 Specific rotation <781S>

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] FULVESTRANT PF 33(5) Pg. 909 Water, Method Ic <921> FULVESTRANT PF 33(5) Pg. 909 Residue on ignition <281> FULVESTRANT PF 33(5) Pg. 909 Related compounds FULVESTRANT PF 33(5) Pg. 909 Diastereoisomer ratio FULVESTRANT PF 33(5) Pg. 909 Assay GAMMA CYCLODEXTRIN PF Microbial limits 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Title 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Molecular weight 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Packaging and storage 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Identification A, B, C 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Specific rotation 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Loss on drying 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Residue on ignition 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Heavy metals 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF Chemical Info 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF Definition 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF USP Reference standards <11> 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF Color and clarity of solution 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF Related compounds 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF Reducing substances 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF Assay 33(4) Pg. 707 GLUCOSAMINE HYDROCHLORIDE PF 33(4) Pg. Specific rotation <781S>

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] 691 GLUCOSAMINE SULFATE POTASSIUM CHLORIDE PF 33(4) Identification Pg. 692 GLUCOSAMINE SULFATE POTASSIUM CHLORIDE PF 33(4) Specific rotation <781S> Pg. 692 GLUCOSAMINE SULFATE POTASSIUM CHLORIDE PF 33(4) Residue on ignition <281> Pg. 692 GLUCOSAMINE SULFATE PF 33(4) Pg. Identification 692 GLUCOSAMINE SULFATE SODIUM CHLORIDE PF 33(4) Pg. Specific rotation <781S> 692 GLUCOSAMINE SULFATE SODIUM CHLORIDE PF 33(4) Pg. Residue on ignition <281> 692 BITARTRATE AND HOMATROPINE Labeling METHYLBROMIDE TABLETS PF 33(4) Pg. 654 HYDROCODONE BITARTRATE AND HOMATROPINE Dissolution <711> METHYLBROMIDE TABLETS PF 33(4) Pg. 654 HYDROPHOBIC COLLOIDAL Title SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Chemical Info SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Definition SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Packaging and storage SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Identification SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Limit of chloride SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Limit of lead SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Water-dispersible substances SILICA PF 33(5) Pg. 976

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] HYDROPHOBIC COLLOIDAL Loss on ignition <733> SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Assay SILICA PF 33(5) Pg. 976 HYOSCYAMINE SULFATE PF Specific rotation <781S> 33(4) Pg. 659 PF 33(4) Pg. 711 Title INOSITOL PF 33(4) Pg. 711 Chemical Info INOSITOL PF 33(4) Pg. 711 Definition INOSITOL PF 33(4) Pg. 711 Packaging and storage INOSITOL PF 33(4) Pg. 711 USP Reference standards <11> INOSITOL PF 33(4) Pg. 711 Clarity of solution INOSITOL PF 33(4) Pg. 711 Color of solution INOSITOL PF 33(4) Pg. 711 Identification INOSITOL PF 33(4) Pg. 711 Conductivity INOSITOL PF 33(4) Pg. 711 Water, Method I <921> INOSITOL PF 33(4) Pg. 711 Barium INOSITOL PF 33(4) Pg. 711 Limit of lead INOSITOL PF 33(4) Pg. 711 Related compounds INOSITOL PF 33(4) Pg. 711 Assay ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS Dissolution <711> PF 33(4) Pg. 659 ISOTRETINOIN CAPSULES PF Dissolution <711> 33(4) Pg. 666 AND CLORSULON Title INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Definition INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Packaging and storage INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Labeling INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON USP Reference standards <11> INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Identification INJECTION PF 33(5) Pg. 921

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] IVERMECTIN AND CLORSULON Bacterial endotoxins <85> INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Sterility <71> INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Other requirements INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Assay for ivermectin INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Assay for clorsulon INJECTION PF 33(5) Pg. 921 IVERMECTIN INJECTION PF Title 33(5) Pg. 913 IVERMECTIN INJECTION PF Definition 33(5) Pg. 913 IVERMECTIN INJECTION PF Packaging and storage 33(5) Pg. 913 IVERMECTIN INJECTION PF Labeling 33(5) Pg. 913 IVERMECTIN INJECTION PF USP Reference standards <11> 33(5) Pg. 913 IVERMECTIN INJECTION PF Identification 33(5) Pg. 913 IVERMECTIN INJECTION PF Bacterial endotoxins <85> 33(5) Pg. 913 IVERMECTIN INJECTION PF Sterility <71> 33(5) Pg. 913 IVERMECTIN INJECTION PF Chromatographic purity 33(5) Pg. 913 IVERMECTIN INJECTION PF Other requirements 33(5) Pg. 913 IVERMECTIN INJECTION PF Assay 33(5) Pg. 913 IVERMECTIN PASTE PF 33(5) Pg. Title 914 IVERMECTIN PASTE PF 33(5) Pg. Definition 914 IVERMECTIN PASTE PF 33(5) Pg. Packaging and storage 914 IVERMECTIN PASTE PF 33(5) Pg. Labeling 914

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] IVERMECTIN PASTE PF 33(5) Pg. USP Reference standards <11> 914 IVERMECTIN PASTE PF 33(5) Pg. Identification 914 IVERMECTIN PASTE PF 33(5) Pg. Chromatographic purity 914 IVERMECTIN PASTE PF 33(5) Pg. Assay 914 IVERMECTIN PF 33(5) Pg. 912 Definition IVERMECTIN TABLETS PF 33(5) Title Pg. 918 IVERMECTIN TABLETS PF 33(5) Definition Pg. 918 IVERMECTIN TABLETS PF 33(5) Packaging and storage Pg. 918 IVERMECTIN TABLETS PF 33(5) USP Reference standards <11> Pg. 918 IVERMECTIN TABLETS PF 33(5) Identification Pg. 918 IVERMECTIN TABLETS PF 33(5) Uniformity of dosage units <905> Pg. 918 IVERMECTIN TABLETS PF 33(5) Limit of 8a-oxo-H2B1a Pg. 918 IVERMECTIN TABLETS PF 33(5) Assay Pg. 918 IVERMECTIN TOPICAL Title SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL Definition SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL Packaging and storage SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL Labeling SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL USP Reference standards <11> SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL Identification SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL Chromatographic purity SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL Assay file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] SOLUTION PF 33(5) Pg. 916 LIGHT MINERAL OIL PF 33(5) Pg. Definition 972 LIGHT MINERAL OIL PF 33(5) Pg. Packaging and storage 972 LIGHT MINERAL OIL PF 33(5) Pg. Labeling 972 LIGHT MINERAL OIL PF 33(5) Pg. USP Reference standards <11> 972 LIGHT MINERAL OIL PF 33(5) Pg. Identification 972 LIGHT MINERAL OIL PF 33(5) Pg. Viscosity <911> 972 Acidity,Readily carbonizable LIGHT MINERAL OIL PF 33(5) Pg. substances, Limit of polycyclic 972 aromatic hydrocarbons, Limit of sulfur compounds, and Solid paraffin MAGALDRATE AND SIMETHICONE ORAL Defoaming activity SUSPENSION PF 33(5) Pg. 923 MAGALDRATE AND SIMETHICONE TABLETS PF Defoaming activity 33(5) Pg. 923 MAGALDRATE AND SIMETHICONE TABLETS PF Defoaming activity 33(5) Pg. 923 MEFLOQUINE HYDROCHLORIDE PF 33(4) Pg. Assay 667 MINERAL OIL PF 33(5) Pg. 962 Chemical Info MINERAL OIL PF 33(5) Pg. 962 Definition MINERAL OIL PF 33(5) Pg. 962 Packaging and storage MINERAL OIL PF 33(5) Pg. 962 Labeling MINERAL OIL PF 33(5) Pg. 962 USP Reference standards <11> MINERAL OIL PF 33(5) Pg. 962 Identification MINERAL OIL PF 33(5) Pg. 962 Neutrality MINERAL OIL PF 33(5) Pg. 962 Acidity MINERAL OIL PF 33(5) Pg. 962 Readily carbonizable substances Limit of polycyclic aromatic MINERAL OIL PF 33(5) Pg. 962 hydrocarbons file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] MINERAL OIL PF 33(5) Pg. 962 Limit of sulfur compounds MINERAL OIL PF 33(5) Pg. 962 Viscosity MINERAL OIL, RECTAL PF 33(5) Packaging and storage Pg. 964 MINERAL OIL, RECTAL PF 33(5) USP Reference standards <11> Pg. 964 MINERAL OIL, RECTAL PF 33(5) Identification Pg. 964 MINERAL OIL, RECTAL PF 33(5) Viscosity Pg. 964 MINERAL OIL, RECTAL PF 33(5) Neutrality Pg. 964 MINERAL OIL, RECTAL PF 33(5) Acidity Pg. 964 MYCOPHENOLATE MOFETIL PF Title 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Chemical Info 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Definition 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Packaging and storage 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF USP Reference standards <11> 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Identification 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Melting range, Class Ia <741> 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Loss on drying <731> 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Residue on ignition <281> 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Heavy metals, Method II <231> 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Related compounds 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF Assay 33(5) Pg. 924 NAPHAZOLINE HYDROCHLORIDE file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] Assay OPHTHALMIC SOLUTION PF 33(5) Pg. 926 TRANSDERMAL Drug release <724> SYSTEM PF 33(5) Pg. 927 NICOTINE TRANSDERMAL Assay SYSTEM PF 33(5) Pg. 927 NORETHINDRONE TABLETS PF Labeling 32(6) Pg. 1736 NORETHINDRONE TABLETS PF Disintegration <701> 32(6) Pg. 1736 NORETHINDRONE TABLETS PF Dissolution <711> 33(3) Pg. 432

General Chapters Monographs:A–C D–N O–S T–Z

file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM]